Generation of an induced pluripotent stem cell line (SJTUGHi001-A) from a patient with Retinitis Pigmentosa carrying c.77C > T mutation in RAX2 gene

被引：0
|
作者：
Bai, Xinyue [1 ,2 ,3 ,4 ,5 ,6 ,7 ]
Chen, Jieqiong [1 ,2 ,3 ,4 ,5 ,6 ,7 ]
Zhao, Xiaohuan [1 ,2 ,3 ,4 ,5 ,6 ,7 ]
Zhu, Xinyue [1 ,2 ,3 ,4 ,5 ,6 ,7 ]
Ding, Xiaoyan [8 ]
Zhang, Ting [1 ,2 ,3 ,4 ,5 ,6 ,7 ]
Jiang, Mei [1 ,2 ,3 ,4 ,5 ,6 ,7 ]
Sun, Xiaodong [1 ,2 ,3 ,4 ,5 ,6 ,7 ]
机构：
[1] Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Sch Med, Dept Ophthalmol, Shanghai, Peoples R China
[2] Natl Clin Res Ctr Eye Dis, Shanghai, Peoples R China
[3] Shanghai Clin Res Ctr Eye Dis, Shanghai, Peoples R China
[4] Shanghai Key Clin Specialty, Shanghai, Peoples R China
[5] Shanghai Key Lab Ocular Fundus Dis, Shanghai, Peoples R China
[6] Shanghai Engn Ctr Visual Sci & Photomed, Shanghai, Peoples R China
[7] Shanghai Engn Ctr Precise Diag & Treatment Eye Dis, Shanghai, Peoples R China
[8] Chinese Acad Sci, CAS Ctr Excellence Mol Cell Sci, Stem Cell Core Facil, Shanghai, Peoples R China
来源：
STEM CELL RESEARCH | 2024年 / 77卷
基金：
中国国家自然科学基金;
关键词：
D O I：
10.1016/j.scr.2024.103390
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
Retinitis pigmentosa (RP) is a group of genetically heterogeneous retinopathy resulting in irreversible loss of vision. Mutations in RAX2 gene has been related to RP with mechanisms unclear. Here, we generated a human induced pluripotent stem cell (iPSC) line from peripheral blood mononuclear cells of a RP patient carrying c.77C > T mutation in RAX2 gene. This cell line was induced by integration-free episomal vectors and validated for pluripotency and differentiation capacity, which may serve as a model to study the role of RAX2 in RP pathogenesis.
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Generation of an induced pluripotent stem cell line (PUMCHi006-A) derived from a patient with pulmonary arterial hypertension carrying heterozygous c.1339 G > A mutation in PTGIS gene
    Zhu, Yong-Jian
    Zhang, Si-Jin
    Wu, Xiao-Han
    Lian, Tian-Yu
    He, Yang-Zhige
    Zhang, Ze-Jian
    Lu, Dan
    Sun, Kai
    Wang, Hui-Fang
    Jing, Zhi-Cheng
    STEM CELL RESEARCH, 2020, 49
  • [32] Generation of an induced pluripotent stem cell line (CSC-44) from a Parkinson's disease patient carrying a compound heterozygous mutation (c.823C>T and EX6 del) in the PARK2 gene
    Marote, Ana
    Pomeshchik, Yuriy
    Goldwurm, Stefano
    Collin, Anna
    Lamas, Nuno J.
    Pinto, Luisa
    Salgado, Antonio J.
    Roybon, Laurent
    STEM CELL RESEARCH, 2018, 27 : 90 - 94
  • [33] Generation of induced pluripotent stem cells (iPSCs) from a retinoblastoma patient carrying a c.2663G>A mutation in RB1 gene
    Zeng, Sicong
    Liu, Lvjun
    Ouyang, Qi
    Zhao, Yan
    Lin, Ge
    Hu, Liang
    Li, Wen
    STEM CELL RESEARCH, 2016, 17 (02) : 208 - 211
  • [34] A human-induced pluripotent stem cell (iPSC) line (SMUSHi006-A) from an ALS patient carrying a mutation c.1126C > T in the FUS gene
    Huang, Chunyan
    Qiu, Liying
    Zhou, Wenyan
    Shao, Congwen
    Wang, Xichun
    Zhang, Qiwen
    Chen, Weilin
    Xiong, Min
    Huang, Min
    Tang, Mei
    Zou, Liangyu
    Xu, Xueqing
    STEM CELL RESEARCH, 2025, 82
  • [35] Generation of human induced pluripotent stem cell line MHHi029-A from a male Fabry disease patient carrying c.959A > T mutation
    Jahn, Christopher
    Juchem, Malte
    Sonnenschein, Kristina
    Gietz, Anika
    Buchegger, Theresa
    Lachmann, Nico
    Goehring, Gudrun
    Behrens, Yvonne Lisa
    Baer, Christian
    Thum, Thomas
    Hoepfner, Jeannine
    STEM CELL RESEARCH, 2024, 77
  • [36] Generation of a human induced pluripotent stem cell line ZZUNEUi030-A from a female patient carrying a heterozygous CALM2 (c.395 A > T) mutation
    Hua, Chongpei
    Sun, Wenrui
    Zhang, Chunjin
    Tian, Xiaoxu
    Qin, Xintong
    Dong, Jianzeng
    Li, Xiaowei
    STEM CELL RESEARCH, 2024, 81
  • [37] Generation of an integration-free induced pluripotent stem cell line (PUMCHi001-A) from a patient with familial partial lipodystrophy type 2 (FPLD2) carrying a heterozygous p.R349W (c.1045C > T) mutation in the LMNA gene
    Xiao, Cheng
    Yu, Miao
    Liu, Jieying
    Wu, Han
    Deng, Mingqun
    Zhang, Qian
    Xiao, Xinhua
    STEM CELL RESEARCH, 2020, 42
  • [38] Derivation of a human induced pluripotent stem cell line (QBRIi007-A) from a patient carrying a homozygous intronic mutation (c.613-7T>G) in the SLC2A2 gene
    Elsayed, Ahmed K.
    Aghadi, Maryam
    Al-Khawaga, Sara
    Husssin, Khalid
    Abdelalim, Essam M.
    STEM CELL RESEARCH, 2020, 44
  • [39] Generation of an induced pluripotent stem cell line from the dermal fibroblasts of a patient with arrhythmogenic right ventricular cardiomyopathy carrying a PKP2/c.2489+1G > A mutation
    Zhou, Danni
    Sun, Yaxun
    Shen, Jiaxi
    Su, Jun
    Gong, Tingyu
    Jiang, Chenyang
    Liang, Ping
    STEM CELL RESEARCH, 2020, 48
  • [40] Generation of an induced pluripotent stem cell line (FDCHI007-A) derived from a patient with developmental and epileptic encephalopathy Type 31 carrying heterozygous c.545C > A mutation in DNM1 gene
    Xu, Yan
    Wang, Xinhua
    Qiu, Tian
    Wang, Ji
    Wang, Yi
    Wu, Bingbing
    Zhou, Yuanfeng
    STEM CELL RESEARCH, 2022, 60
12345